Home > Market > Market Stats >  Natco Pharma

Company Summary

NATCO PHARMA SUMMARY

Natco Pharma is trading 0.00% lower at Rs 579.95 as compared to its last closing price. Natco Pharma has been trading in the price range of 0.0 & 0.0. Natco Pharma has given -35.99% in this year & 2.13% in the last 5 days.

 

Natco Pharma has TTM P/E ratio 27.16 as compared to the sector P/E of 27.15. There are 14 analysts who have initiated coverage on Natco Pharma. There are 2 analysts who have given it a strong buy rating & 3 analysts have given it a buy rating. 2 analysts have given the stock a sell rating.

 

The company posted a net profit of 56.8 Crores in its last quarter.

 

Listed peers of Natco Pharma include Suven Pharmaceuticals (0%), Alembic Pharmaceuticals (0%), Natco Pharma (0%) etc.

FAQs about Natco Pharma

Natco Pharma is trading at 579.95 as on -. This is 0.00% lower as compared to its previous closing price of 579.95
The market capitalization of Natco Pharma is 10570.97 Cr as on -.
The average broker rating on Natco Pharma is Hold. The breakup of analyst rating is given below -
  • 0 analysts have given a strong sell rating
  • 2 analysts have given a sell rating
  • 7 analysts have given a hold rating
  • 3 analysts have given a buy rating
  • 2 analysts have given a strong buy rating
The 52 wk high for Natco Pharma is 942.15 whereas the 52 wk low is 559.0
Natco Pharma can be analyzed on the following key metrics -
  • TTM P/E: 27.16
  • Sector P/E: 27.15
  • Dividend Yield: 1.08%
  • D/E ratio: -
Natco Pharma reported a net profit of 170 Cr in 2022.

Recommended For You

Trending Stocks

×
Get alerts on WhatsApp
Set Preferences My ReadsWatchlistFeedbackRedeem a Gift CardLogout